Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Science (008930 KS)
Watchlist
70
Analysis
Health Care
•
South Korea
Hanmi Science Co., Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
LG Corp
•
27 Apr 2021 21:56
Closing the Gap: Korean Holdcos Vs. Opcos
In this insight, we highlight the closing of the pricing gaps between the major Korean holdcos and opcos, especially with the upcoming end of the...
Douglas Kim
Follow
615 Views
Share
bearish
•
Amorepacific Holdings
•
16 Mar 2020 03:26
Korean Stub Trade in a New Era: List of Holdcos Having Single Stock Futures
We now have the across-the-board shorting restriction in Korea for the next six months. It means that we will have to adjust our approach on most...
Sanghyun Park
Follow
601 Views
Share
bullish
•
Quantitative Analysis
•
03 Dec 2019 17:40
Korea - Massive Covering on Hyundai Motor, Shorts Increase on SK Companies
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 29 November.Current...
Brian Freitas
Follow
758 Views
Share
bearish
•
Celltrion Inc
•
10 Aug 2017 19:54
NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move
Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...
Sanghyun Park
Follow
1.7k Views
Share
bullish
•
Yuhan Corp
•
27 Dec 2016 15:50
Yuhan Corp: (Part I) - Oversold on Hanmi Pharma Scares
Why Look atYuhan Corp?Yuhan Corp shares are quite interesting at current levels. It is currently trading at 214,000 won, which is down 38% (A...
Douglas Kim
Follow
1.4k Views
Share
First
Previous
10
11
12
13
14
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x